---
title: "GLOBALINK INVESTMENT INC C/WTS 03/12/2026 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.28"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/254683932.md"
published_at: "2025-08-26T20:11:24.000Z"
---

# GLOBALINK INVESTMENT INC C/WTS 03/12/2026 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.28

EPS: As of FY2025 Q2, the actual value is USD -0.28.

### Segment Revenue

-   The company has not commenced any operations and will not generate operating revenues until after the completion of its initial Business Combination.

### Operational Metrics

-   For the three months ended June 30, 2025, the company reported a net loss of $893,896, compared to a net loss of $217,185 for the same period in 2024.
-   For the six months ended June 30, 2025, the net loss was $1,632,451, compared to $592,492 for the same period in 2024.
-   Operating expenses for the three months ended June 30, 2025, were $317,427, compared to $469,611 for the same period in 2024.
-   Operating expenses for the six months ended June 30, 2025, were $637,683, compared to $1,066,744 for the same period in 2024.

### Cash Flow

-   Cash used in operating activities for the six months ended June 30, 2025, was $430,447, compared to $1,559,688 for the same period in 2024.
-   As of June 30, 2025, the company had $22,170 in cash available to meet working capital needs and a working capital deficit of approximately $7.9 million.

### Unique Metrics

-   The company has entered into multiple promissory notes with Public Gold Marketing Sdn. Bhd. for working capital, with a total outstanding balance of $4,570,422 as of June 30, 2025.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is focused on completing a Business Combination by September 9, 2025, or up to December 9, 2025, if extended. The company intends to complete a business combination before the mandatory liquidation date.
-   **Non-Core Business**: The company has entered into a Merger Agreement with Alps Life Sciences Inc, which involves merging with Alps Global Holding Pubco and Alps Biosciences Merger Sub, with the aim of Alps Holdco becoming a wholly-owned subsidiary of PubCo. The company has also engaged in PIPE Investment agreements to raise additional capital for use by PubCo following the closing of the Business Combination.

### Related Stocks

- [GLLIW.US - GLOBALINK INVESTMENT INC C/WTS 03/12/2026 (TO PUR COM)](https://longbridge.com/en/quote/GLLIW.US.md)
- [ALPWF.US - ALPS GROUP INC C/WTS (TO PUR ORD)](https://longbridge.com/en/quote/ALPWF.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.